Cadrenal Therapeutics (CVKD) vs PRF Technologies (PRFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cadrenal Therapeutics is the larger company by market cap ($3.3 million vs $3.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVKD | PRFX |
|---|---|---|
| Share price | $0.9299 | $0.8735 |
| Market cap | $3.32M | $3.06M |
| 1-day change | +0.03% | +1.72% |
| EPS (TTM) | $-4.91 | $-4.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $7.95 |
| 52-week low | $0.85 | $0.851 |
| Distance from 52-week high | -93.59% | -89.01% |
| Analyst consensus | none | — |
| Avg. price target upside | +1405.54% | — |
| Average volume | 458.82K | 294.15K |
| Shares outstanding | 3.57M | 3.50M |
| Employees | 5 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cadrenal Therapeutics
CVKD stock →Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About PRF Technologies
PRFX stock →PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
CVKD vs PRFX FAQ
Which is bigger, Cadrenal Therapeutics or PRF Technologies?
Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $3.32M compared with $3.06M for PRF Technologies (PRFX).
Are Cadrenal Therapeutics and PRF Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.